LEXARIA BIOSCIENCE CORP. Operating Lease, Liability, Current
LEXARIA BIOSCIENCE CORP. (LEXX) had Operating Lease, Liability, Current of $33.03 thousand as of 2026-05-31, per its 10-Q filed 2026-07-13.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-07-13
- 2026-05-31: Operating Lease, Liability, Current $33.03K.
- 2026-02-28: Operating Lease, Liability, Current $32.06K.
- 2025-11-30: Operating Lease, Liability, Current $31.10K.
- 2025-08-31: Operating Lease, Liability, Current $30.42K.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2026-05-31 | $33.03K 10-Q · filed 2026-07-13 |
| 2026-02-28 | $32.06K 10-Q · filed 2026-04-13 |
| 2025-11-30 | $31.10K 10-Q · filed 2026-01-13 |
| 2025-08-31 | $30.42K 10-Q · filed 2026-07-13 |
| 2025-05-31 | $29.87K 10-Q · filed 2025-07-14 |
| 2025-02-28 | $29.34K 10-Q · filed 2025-04-14 |
| 2024-11-30 | $28.81K 10-Q · filed 2025-01-10 |
| 2024-08-31 | $28.05K 10-K · filed 2025-11-28 |
| 2022-05-31 | $41.83K 10-Q · filed 2022-07-14 |
| 2022-02-28 | $41.08K 10-Q · filed 2022-04-11 |
| 2021-11-30 | $40.34K 10-Q · filed 2022-01-14 |
| 2021-08-31 | $39.40K 10-Q · filed 2022-07-14 |
| 2021-05-31 | $38.48K 10-Q · filed 2021-07-15 |
| 2021-02-28 | $37.58K 10-Q · filed 2021-04-14 |
| 2020-11-30 | $36.70K 10-Q · filed 2021-01-14 |
| 2020-08-31 | $36.04K 10-Q · filed 2021-07-15 |
| 2019-08-31 | $0.00 10-K · filed 2020-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |